Skip to main content

Should the SEC Investigate Medifast Like It's Investigating Pre-Paid Legal?

Fraud Discovery Institute and its sister website iBusiness Reporting delivered duo salvos against Medifast (NYSE: MED) today releasing reports questioning the company's financial disclosures about its Take Shape for Life division which is responsible for Medifast's recent growth in revenues and profits. In addition, Medifast announced that it was replacing its auditors who came under fire by Minkow and this blog in June 2009, when we suggested that Medifast replace them because of their poor track record as detailed in reports issued by the Public Company Accounting Oversight Board.

Both Fraud Discovery Institute co-founder Barry Minkow, a convicted felon with a long track record of fraud busting and iBusiness Reporting reporter William Lobdell who is a former LA Times investigative reporter have publicly disclosed holding short positions in Medifast securities. I do research for Fraud Discovery on InterOil and I do not own any securities in InterOil, Medifast, or Pre-Paid Legal, long or short. In addition, I researched Medifast's former auditors for Fraud Discovery.

Should Medifast be investigated by the Securities and Exchange Commission?

According to former LA Times investigative reporter and bestselling book author William Lobdell's report in iBusiness Reporting:
Despite being an obvious multi-level marketing operation, as defined by the Federal Trade Commission and others, Medifast and Take Shape for Life officials work hard to avoid the label, perhaps in part because it might tip off investors that the company's recent sales increases would be difficult to maintain over time (and when jobs return to the economy) and also because some multi-level marketing efforts are often labeled pyramid schemes destine to collapse once the pool of new recruits dries up.
Lobdell goes on to suggest that Medifast may be in violation of SEC Rule 10b-5 governing securities fraud:
Whether Medifast needs to disclose it's a multi-level marketing company to prospective independent sales people and investors is a matter of the Securities and Exchange Commission. According to SEC regulations, it's illegal ... "to make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading ..."
More details from Lobdell's report can be read here and Fraud Discovery's press release can be read here.

Comparing Medifast to Prepaid Legal, another company under investigation by the SEC

Both Barry Minkow and William Lobdell compare Medifast's compensation plans for its Take Shape for Life division with similar plans at multi-level marketing company Pre-Paid Legal (NYSE: PPD) another company under scrutiny by Minkow. Fraud Discovery Institute has set up two websites detailing its investigative reports on Medifast and Prepaid Legal called "" and "Ponzi Plus Pyramid Equals Prepaid", respectively.

After Fraud Discovery's released its reports questioning Pre-Paid Legal's financial disclosures, the Securities and Exchange Commission and the Federal Trade Commission started an investigation of the company and the SEC recently expanded its probe. According to Pre-Paid Legal's announcement:
The subpoena requests us to provide documents relating to certain membership information, member complaints about provider law firms, our efforts to achieve compliance with all payment card industry requirements, the resignation of Harland C. Stonecipher as Chief Executive Officer and President and the resignation of Tom Smith as a director.
In its recent press release, Fraud Discovery points out five "similarities" between Medifast and Pre-Paid Legal:
1. Both Medifast and Pre-Paid Legal Services report dismally low earnings for the vast majority of "coaches" and "associates." From July to December 2009, 53 percent of Medifast's "active" health coaches made an average of $97 per month, and this "average" is inflated as it conveniently excludes all coaches who made less than $25 per month. In 2009, Pre-Paid Legal Services reported that only 1.6 percent of vested sales associates personally sold more than 10 memberships. With annual commissions of $16 or $25 per sale of a family plan for associates selling less than 25 memberships, this means that 98.4 percent of vested associates make less than $250 per year.

2. Representatives of Medifast and Pre-Paid Legal Services are incentivized to recruit, rather than to sell the products. The representatives above the salesperson in both companies are collectively paid much more in commission on each sale than the associate who actually made the sale. It is nearly impossible to make a reasonable income simply selling the products or services of Medifast or Pre-Paid Legal Services, pushing the representatives to recruit new members in the hope of earning more.

3. Both Medifast and Pre-Paid Legal Services have 10 levels of commission payouts. For an individual sale, the person making the sale will receive a small commission, while 9 other levels will receive commissions that, collectively, usually exceed the commission the actual salesperson received.

4. What's to hide? Neither Medifast nor Pre-Paid Legal Services disclose their "churn rates." While both companies report the number of "active" coaches or associates at the end of the year - and Pre-Paid Legal Services also reports the number of associates recruited during the year, they deliberately fail to disclose the total number of representatives at the end of the year or the number of people who have quit during the year. Failing to disclose these key figures effectively conceals the failure rate of the recruits.

5. What's to hide, Part II? Neither Medifast nor Pre-Paid Legal Services discloses the real average income for their coaches or associates. Medifast appears to disclose average income but excludes all coaches earning $25 or less in monthly commission from its calculations, effectively making the reported "average" a completely fictional number.

"Multi-level marketing is not direct selling and is nothing more than a money transfer game where the product or service is merely the excuse used to move the money from those at the bottom of the pyramid to the exclusive minority at the top of the pyramid," Minkow said.
Both Minkow and Lobdell suggest that the SEC, like it's investigating Pre-Paid Legal, should also investigate Medifast's financial disclosures.

Medifast replaces its auditors

According to Going Concern blogger Caleb Newquist:
McGladrey & Pullen/RSM McGladrey has been named the new audit/tax firm of Medifast, the company announced in a filing last Friday. The Company dropped Bagell, Josephs, Levine and Company LLP of New Jersey who was purchased by Friedman LLP, citing/blaming Sarbanes-Oxley for reducing the number of accounting firms that have the “extensive resources and experience with public companies on a national and regional basis to better serve Medifast.”
In June 2009, I helped Fraud Discovery research Medifast's auditors and noted that 50% of their audits inspected by the Public Company Accounting Oversight Board were materially deficient.

Not backing down from Medifast lawsuit

Minkow, Lobdell, along with acclaimed forensic accountant Tracy Coenen and pyramid scheme expert Robert L. FitzPatrick were recently sued by Medifast claiming defamation. I criticized that lawsuit saying:
Like your complaints to investors and securities regulators, your lawsuit fails to provide a detailed and credible substantive line-by-line rebuttal of serious allegations of improprieties concerning Medifast's business model, marketing practices, and financial disclosures made in reports issued by Fraud Discovery Institute....

Instead, the lawsuit reads like a cheaply produced late-night infomercial for insomniacs, rambles about the purported "health" benefits of Medifast products, and rants that Fraud Discovery Institute's reports are false. To support your claims of defamation, the lawsuit refers to self-serving claims on Medifast's website and disclosures in SEC filings which certain Defendants allege are false and misleading.
Tracy Coenen's rebuttal of Medifast's allegations can be read here. Barry Minkow's and William Lobdell's response can be found here.

None of them are backing down from continuing to investigate financial reporting irregularities at Medifast despite its frivilous lawsuit and I stand behind my friends, too. Medifast can shove its retaliatory lawsuit up their rear ends.

Written by:

Sam E. Antar

Recommending Reading:

Fraud Files Blog - Medifast changes auditors: Was Barry Minkow right when he criticized former auditors? by Tracy Coenen


I am a convicted felon and a former CPA. As the criminal CFO of Crazy Eddie, I helped Eddie Antar and other members of his family mastermind one of the largest securities frauds uncovered during the 1980's. I committed my crimes, simply because I could.

If it weren't for the efforts of the FBI, SEC, Postal Inspector's Office, US Attorney's Office, and class action plaintiff's lawyers who investigated, prosecuted, and sued me, I would still be the criminal CFO of Crazy Eddie today.

I do research for Fraud Discovery on InterOil and I do not own any securities in InterOil, Medifast, or Pre-Paid Legal, long or short. In addition, I researched Medifast's former auditors for Fraud Discovery.


Aidan said…
Really useful blog.Good work keeping this updated!Thanks a lot!

prepaid legal
Keith said…
This article is really not accurate because Medifast has a product that works. A product that works in the weight loss field is quite rare.

Medifast is not a scam, it is a company that has had explosive results helping people lose weight.

Why do they not report people that earn LESS than $25.00? Because that is the minimum payout. Google has a minimum payout for $100.00 on their AdSensa program....does anyone think Google is a scam?

Also, you have a link on this page for Sensa???? Now that is questionable!

Popular Posts

Did a Clever SEC Bait Goldman Sachs into Compounding Its Legal Problems With the "Kiss of Death" Message?

Updated: At 3:48 AM ET 04/20/2010 on bottom

The Kiss of Death

In filing its lawsuit against Goldman Sachs (NYSE: GS) on a Friday, the Securities and Exchange Commission sent what I call the "kiss of death" message to the embattled company. In other words, the SEC wanted to stick it to Goldman Sachs and Fabrice Tourre, the Executive Director of Goldman Sachs International, who is also a defendant in the complaint. While the SEC as a practice does inform target companies and individuals of an impending enforcement action, it does not always tell them exactly when such an action will be filed.

Apparently, the SEC filed its lawsuit without giving Goldman Sachs the heads up that it was planning to file it that day. Business Insider observed that Goldman Sachs was clearly unprepared to respond to the complaint as news of the lawsuit dominated the headlines all day. Goldman issued a short denial around noon and issued an extensive denial late in the afternoon, after most people had … CEO Patrick Byrne Sleeps With a Gun

Suggested Reading: Hatchet Man Judd Bagley's Downward Spiral: Junkie, Confessed Criminal, Admitted Adulterer by Sam Antar (here), and Closing the File on a Criminal and Junkie Named Judd Bagley by Gary Weiss (here)

In numerous blog posts in the past, and in widespread media coverage, evidence has accumulated for years that CEO (NASDAQ: OSTK) Patrick Byrne has shown signs of being mentally unbalanced and paranoid.

Byrne has blamed his company's financial woes on an unnamed "Sith Lord." He hired paid goons to stalk his real and imagined adversaries and to write lengthy conspiracy theories on the Internet. Byrne has close ties with Bo Gritz. The Anti-Defamation League lists Bo Gritz as a far-right extremist with “extensive connections to both white supremacists and anti-government groups and leaders.”

Patrick Byrne's infamous temper tantrums when he doesn’t get want he wants are well documented too. He made obscene and misogynistic commen…

Nature's Sunshine Products, Willbros Group, Cal Dive International, and BSQUARE Violate S.E.C. Rules on Calculating EBITDA

Nature’s Sunshine Products (NASDAQ: NATR), Willbros Group (NYSE: WG), Cal Dive International (NYSE: DVR), and BSQUARE (NASDAQ: BSQR) have recently issued earnings reports which include a calculation of EBITDA (earnings before interest, taxes, depreciation, and amortization) that apparently does not comply with Securities and Exchange Commission interpretations for Regulation G governing such non-GAAP financial measures. In each case, their erroneous EBITDA calculations have enabled them to significantly distort their financial performance by erroneously reporting a positive EBITDA, when they should have reported a negative EBITDA in the latest quarter.

How EBITDA is supposed to be calculated under Regulation G

According to the S.E.C. Compliance & Disclosure Interpretations, EBITDA is defined under Regulation G as net income (not operating income) before net interest, taxes, depreciation, and amortization. See below:

Question 103.01Question: Exchange Act Release No. 47226 describes E…

InterOil, John Thomas Financial, and Clarion Finanz: Anatomy of a Stock Market Manipulation Scheme

In this blog post, I will provide evidence of what I believe is a stock market manipulation scheme involving InterOil (NYSE: IOC), John Thomas Financial, and Clarion Finanz AG. I believe that InterOil with the assistance of Clarion Finanz concealed John Thomas Financial’s involvement in helping it raise $95 million through a private placement of convertible debt securities.

Clarion Finanz acted as a buffer between InterOil and John Thomas Financial to help InterOil hide John Thomas Financial's role in raising funds. Afterwards, InterOil filed false and misleading reports with the Securities and Exchange Commission in an effort to conceal John Thomas Financial’s role in helping the company raise $95 million in convertible debt.

Carl Caserta, who in 1991 was barred by the Securities and Exchange Commission from “association with any broker, dealer, or investment advisor” played a role in helping InterOil use John Thomas Financial to obtain funds from investors. InterOil, John Thoma…

Class Action Complaint against Amedisys uses Sarbanes-Oxley Act Corporate Governance Provisions to Battle Alleged Corporate Malfeasance

Updated at bottom of article

Last week, Pomerantz Haudek Grossman & Gross LLP filed a class action lawsuit against Amedisys (NASDAQ: AMED) charging the company, its CEO William F. Borne and its CFO Dale E. Redman with securities fraud.  In the next few days, Bernstein Liebhard LLP and Finkelstein Thompson LLP filed similar class action lawsuits against the company. The lawsuits allege that Amedisys abused Medicare's reimbursement system for at-home therapy care based on a compelling analysis of company revenues in an April 27 Wall Street Journal article.

In addition, the lawsuits innovatively utilize a provision under Section 406 of the Sarbanes-Oxley Act 2002 which provides a back-door way for investors to force ethical corporate governance and sue public companies for malfeasance. That provision requires Senior Financial Officers, such as the CEO and CFO of public companies, to abide by a strict code of ethics which broadly defines corporate malfeasance and effectively makes…